\-\ Texto\\:\\ \ \(0\)\
\-\ enlarged\\ right\\ distal\\ femur\\,\\ tender\\ to\\ palpation\\,\\ without\\ erythema\\,\\ ecchymosis\\,\\ or\\ effusion\\.\ \(0\)\
\-\ patient\\ underwent\\ chemotherapy\\ and\\ limb\\-salvage\\ therapy\\ and\\ is\\ doing\\ well\\.\ \(0\)\
\-\ knee\\,\\ rt\\ \\(ap\\,lat\\,sunrise\\)\\:\ \(0\)\
\-\ an\\ area\\ of\\ destruction\\ extends\\ over\\ approximately\\ a\\ 7cm\\ segment\\ of\\ the\\ medial\\ aspect\\ of\\ the\\ distal\\ shaft\\ of\\ the\\ right\\ femur\\.\\ \\ approximately\\ 1\\/4\\ of\\ the\\ width\\ of\\ the\\ shaft\\ has\\ been\\ destroyed\\ with\\ an\\ irregular\\ overlying\\ cortex\\ and\\ a\\ mottled\\ area\\ throughout\\ the\\ adjacent\\ medullary\\ cavity\\ which\\ shows\\ both\\ areas\\ of\\ bone\\ destruction\\ and\\ bone\\ production\\.\\ \\ some\\ elevation\\ of\\ the\\ periosteum\\ has\\ a\\ tendency\\ towards\\ layering\\ as\\ well\\ as\\ some\\ dense\\ spicules\\ of\\ bone\\ arranged\\ at\\ right\\ angles\\ to\\ the\\ underlying\\ bone\\.\\ \\ there\\ appears\\ to\\ be\\ an\\ associated\\ soft\\ tissue\\ mass\\ associated\\ with\\ this\\ lesion\\ and\\ the\\ growth\\ plate\\ at\\ the\\ distal\\ end\\ of\\ the\\ femur\\ is\\ not\\ involved\\.\\ \ \(0\)\
\-\ ct\\ scan\\ of\\ the\\ right\\ distal\\ femur\\:\ \(0\)\
\-\ right\\ distal\\ femur\\ destructive\\ lytic\\ lesion\\ with\\ significant\\ cortical\\ breakthrough\\ and\\ periosteal\\/soft\\ tissue\\ component\\ extending\\ from\\ the\\ distal\\ diaphysis\\ into\\ the\\ metaphysis\\ with\\ probable\\ involvement\\ of\\ the\\ more\\ medial\\ physeal\\ plate\\.\\ \\ the\\ subarticular\\ epiphyses\\ do\\ not\\ appear\\ involved\\.\\ \\ \ \(0\)\
\-\ three\\ phase\\,\\ multiple\\ area\\ and\\ total\\ body\\ bone\\ scan\\:\ \(0\)\
\-\ the\\ immediate\\ flow\\ portion\\ of\\ the\\ study\\ shows\\ a\\ moderately\\ intense\\ hyperemic\\ response\\ to\\ the\\ distal\\ one\\-third\\ of\\ the\\ right\\ femur\\.\\ \\ the\\ left\\ femur\\ and\\ knee\\ shows\\ normal\\ perfusion\\.\\ \\ the\\ immediate\\ blood\\ pool\\ images\\ show\\ a\\ mild\\ to\\ moderate\\,\\ basically\\ symmetrical\\,\\ hyperemic\\ response\\ of\\ the\\ distal\ \(0\)\
\-\ one\\-half\\ of\\ the\\ right\\ femur\\ to\\ the\\ physes\\.\\ \\ there\\ are\\ moderately\\ intense\\ irregular\\ hyperemic\\ areas\\,\\ particularly\\ involving\\ the\\ right\\ lateral\\ growth\\ plate\\ area\\,\\ and\\ on\\ the\\ medial\\ aspect\\,\\ an\\ area\\ smaller\\ in\\ size\\ but\\ equal\\ in\\ intensity\\.\\ \\ this\\ area\\ extends\\ proximally\\ along\\ the\\ medial\\ aspect\\ of\\ the\\ distal\\ femoral\\ shaft\\.\\ \\ the\\ overall\\ pattern\\ is\\ suggestive\\ of\\ cortical\\ expansion\\.\\ \\ the\\ left\\ femur\\ and\\ knee\\ shows\\ normal\\ blood\\ pool\\ activity\\.\\ \\ the\\ total\\ body\\ bone\\ images\\ acquired\\ approximately\\ 2\\.5\\ to\\ 3\\.0\\ hours\\ post\\-injection\\ show\\ moderately\\ intense\\ uptake\\ of\\ the\\ radiopharmaceutical\\ bilaterally\\ within\\ the\\ proximal\\ humerus\\ involving\\ the\\ physes\\.\\ \\ the\\ intensity\\ of\\ uptake\\ decreases\\ going\\ from\\ anterior\\ to\\ posterior\\.\\ \\ the\\ pattern\\ is\\ symmetrical\\ comparing\\ the\\ left\\ humerus\\ with\\ the\\ right\\ humerus\\.\\ \\ intense\\ uptake\\ is\\ noted\\ in\\ the\\ right\\ distal\\ femoral\\ physes\\ extending\\ proximally\\ in\\ an\\ irregular\\ pattern\\ to\\ approximatly\\ midshaft\\.\\ \\ there\\ appears\ \(0\)\
\-\ to\\ be\\ cortical\\ expansion\\ throughout\\ this\\ area\\ with\\ a\\ heterogeneous\\ uptake\\ and\\ pattern\\ in\\ the\\ distal\\ one\\-third\\ of\\ the\\ femoral\\ shaft\\.\\ \\ the\\ pattern\\ of\\ uptake\\ is\\ irregular\\ with\\ intense\\ localization\\ involving\\ the\\ lateral\\ aspect\\ of\\ the\\ physes\\ extending\\ proximately\\ along\\ the\\ femoral\\ shaft\\.\\ \\ the\\ medial\\ aspect\\ also\\ shows\\ intense\\ uptake\\ that\\ extends\\ proximally\\ for\\ only\\ a\\ short\\ distance\\.\\ \\ there\\ is\\ a\\ central\\ area\\ of\\ decreased\\ activity\\ between\\ the\\ medial\\ and\\ lateral\\ areas\\ just\\ proximal\\ to\\ the\\ midportion\\ of\\ the\\ physes\\.\\ \\ there\\ is\\ a\ \(0\)\
\-\ frank\\ lytic\\ area\\ involving\\ the\\ proximal\\ medial\\ portion\\ of\\ the\\ femoral\\ shaft\\.\\ the\\ pattern\\ of\\ uptake\\ from\\ the\\ midright\\ shaft\\ to\\ the\\ distal\\ one\\-third\\ is\\ irregular\\ with\\ heterogeneous\\ uptake\\.\\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ mri\\ of\\ the\\ right\\ femur\\:\ \(0\)\
\-\ there\\ is\\ a\\ soft\\ tissue\\ mass\\ involving\\ the\\ medial\\ aspect\\ of\\ the\ \(0\)\
\-\ right\\ distal\\ femur\\,\\ which\\ wraps\\ around\\ the\\ distal\\ femur\\.\\ \\ medially\\,\\ there\\ is\\ destruction\\ of\\ the\\ cortex\\.\\ \\ the\\ medullary\\ cavity\\ is\\ filled\\ with\\ tumor\\ from\\ the\\ distal\\ diaphysis\\ to\\ the\\ epiphyseal\\ plate\\.\\ \\ scattered\\ regions\\ of\\ abnormal\\ signal\\ and\\ enhancement\\ involve\\ the\\ epiphysis\\,\\ suspicious\\ for\\ involvement\ \(0\)\
\-\ across\\ the\\ epiphyseal\\ plate\\.\\ \\ entire\\ dimensions\\ of\\ the\\ tumor\\ are\\ 14\\.9\\ x\\ 5\\.8\\ x\\ 5\\.9\\ cm\\.\\ \\ the\\ adjacent\\ soft\\ tissues\\ and\\ muscles\\ demonstrate\\ edema\\.\\ \\ the\\ mass\\ appears\\ to\\ be\\ fairly\\ well\\ encapsulated\\,\\ however\\,\\ where\\ it\\ closely\\ abuts\\ the\\ muscles\\ of\ \(0\)\
\-\ the\\ lower\\ thigh\\,\\ local\\ invasion\\ cannot\\ be\\ excluded\\.\\ \\ the\\ lesion\\ demonstrates\\ uniform\\ low\\ signal\\ on\\ t1\\ and\\ heterogeneous\\ high\\ signal\\ on\\ t2\\.\ \(0\)\
\-\ osteosarcoma\ \(92\)\
\-\ osteosarcoma\\ \ \(28\)\
\-\ ewings\\ tumor\ \(0\)\
\-\ fibrosarcoma\ \(14\)\
\-\ lymphoma\ \(373\)\
\-\ leukemia\\ \ \(20\)\
\-\ osteomyelitis\ \(170\)\
\-\ 4\\ weeks\\ of\\ right\\ thigh\\ \\/\\ knee\\ pain\\ without\\ a\\ history\\ of\\ trauma\\,\\ illness\\,\\ or\\ infection\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ femur\\:\\ 0\\.06364749042350412\ \(0\)\
\-\ shaft\\:\\ 0\\.0508336611464232\ \(0\)\
\-\ physes\\:\\ 0\\.050458038467948586\ \(0\)\
\-\ distal\\:\\ 0\\.050070659244526444\ \(0\)\
\-\ uptake\\:\\ 0\\.03902279798499094\ \(0\)\
\-\ intense\\:\\ 0\\.03900912916222506\ \(0\)\
\-\ area\\:\\ 0\\.03493753763966725\ \(0\)\
\-\ medial\\:\\ 0\\.0314172357883914\ \(0\)\
\-\ plate\\:\\ 0\\.03076809576733651\ \(0\)\
\-\ hyperemic\\:\\ 0\\.029034814147787337\ \(0\)\
\-\ pattern\\:\\ 0\\.02815898568164895\ \(0\)\
\-\ one\\-third\\:\\ 0\\.026325294064070207\ \(0\)\
\-\ irregular\\:\\ 0\\.024485248940419393\ \(0\)\
\-\ proximally\\:\\ 0\\.023634973766341785\ \(0\)\
\-\ femoral\\:\\ 0\\.023354870809222734\ \(0\)\
\-\ aspect\\:\\ 0\\.023140447711063425\ \(0\)\
\-\ involving\\:\\ 0\\.02154028206898918\ \(0\)\
\-\ moderately\\:\\ 0\\.021050399962250742\ \(0\)\
\-\ humerus\\:\\ 0\\.018951197483490948\ \(0\)\
\-\ bone\\:\\ 0\\.01830547139189543\ \(0\)\
\-\ destruction\\:\\ 0\\.01819137316306857\ \(0\)\
\-\ knee\\:\\ 0\\.017807417945748714\ \(0\)\
\-\ shows\\:\\ 0\\.016877684624489072\ \(0\)\
\-\ right\\:\\ 0\\.01684082215292445\ \(0\)\
\-\ extends\\:\\ 0\\.015963494119008426\ \(0\)\
\-\ symmetrical\\:\\ 0\\.01586115390219014\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.015464170170923426\ \(0\)\
\-\ pool\\:\\ 0\\.01439326417872465\ \(0\)\
\-\ the\\:\\ 0\\.014103016112007804\ \(0\)\
\-\ appears\\:\\ 0\\.013710038020677795\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.013543944641357782\ \(0\)\
\-\ cortical\\:\\ 0\\.013427046769723327\ \(0\)\
\-\ thigh\\:\\ 0\\.013426389935560246\ \(0\)\
\-\ diaphysis\\:\\ 0\\.013206927352845952\ \(0\)\
\-\ immediate\\:\\ 0\\.012849750006071305\ \(0\)\
\-\ there\\:\\ 0\\.01279024266559615\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.01277606486063068\ \(0\)\
\-\ limb\\-salvage\\:\\ 0\\.012665974747078302\ \(0\)\
\-\ periosteal\\/soft\\:\\ 0\\.012665974747078302\ \(0\)\
\-\ proximately\\:\\ 0\\.012665974747078302\ \(0\)\
\-\ midright\\:\\ 0\\.012665974747078302\ \(0\)\
\-\ areas\\:\\ 0\\.012393737807095115\ \(0\)\
\-\ extending\\:\\ 0\\.012382409693274988\ \(0\)\
\-\ response\\:\\ 0\\.012307238306934603\ \(0\)\
\-\ expansion\\:\\ 0\\.012098701833271283\ \(0\)\
\-\ medullary\\:\\ 0\\.01179881673176484\ \(0\)\
\-\ sunrise\\:\\ 0\\.011670073625584127\ \(0\)\
\-\ destroyed\\:\\ 0\\.011670073625584127\ \(0\)\
\-\ post\\-injection\\:\\ 0\\.011670073625584127\ \(0\)\
\-\ approximatly\\:\\ 0\\.011670073625584127\ \(0\)\
\-\ approximately\\:\\ 0\\.011395766493774065\ \(0\)\
\-\ muscles\\:\\ 0\\.011215125109857605\ \(0\)\
\-\ basically\\:\\ 0\\.01108750881508389\ \(0\)\
\-\ 14\\.9\\:\\ 0\\.01108750881508389\ \(0\)\
\-\ proximal\\:\\ 0\\.011058375783219892\ \(0\)\
\-\ lytic\\:\\ 0\\.01099162596893035\ \(0\)\
\-\ cavity\\:\\ 0\\.01074811669176055\ \(0\)\
\-\ growth\\:\\ 0\\.010677160908454884\ \(0\)\
\-\ spicules\\:\\ 0\\.010674172504089953\ \(0\)\
\-\ wraps\\:\\ 0\\.010674172504089953\ \(0\)\
\-\ total\\:\\ 0\\.01057390800837999\ \(0\)\
\-\ cortex\\:\\ 0\\.010507077944689566\ \(0\)\
\-\ involved\\:\\ 0\\.010300028181356067\ \(0\)\
\-\ 7cm\\:\\ 0\\.009870126831768944\ \(0\)\
\-\ one\\-half\\:\\ 0\\.009870126831768944\ \(0\)\
\-\ 5\\.8\\:\\ 0\\.009870126831768944\ \(0\)\
\-\ signal\\:\\ 0\\.009711527285658529\ \(0\)\
\-\ is\\:\\ 0\\.009694668592840096\ \(0\)\
\-\ midshaft\\:\\ 0\\.009678271382595778\ \(0\)\
\-\ midportion\\:\\ 0\\.009678271382595778\ \(0\)\
\-\ 5\\.9\\:\\ 0\\.009678271382595778\ \(0\)\
\-\ breakthrough\\:\\ 0\\.00950904288308948\ \(0\)\
\-\ subarticular\\:\\ 0\\.00950904288308948\ \(0\)\
\-\ tendency\\:\\ 0\\.009357662831856971\ \(0\)\
\-\ comparing\\:\\ 0\\.00922072291834501\ \(0\)\
\-\ activity\\:\\ 0\\.009212777668912467\ \(0\)\
\-\ throughout\\:\\ 0\\.009191802661781398\ \(0\)\
\-\ lat\\:\\ 0\\.009095706572095543\ \(0\)\
\-\ involvement\\:\\ 0\\.008999823725942002\ \(0\)\
\-\ soft\\:\\ 0\\.008969511913765302\ \(0\)\
\-\ portion\\:\\ 0\\.00889427197516979\ \(0\)\
\-\ intensity\\:\\ 0\\.008875490449365808\ \(0\)\
\-\ fibrosarcoma\\:\\ 0\\.008874225710274769\ \(0\)\
\-\ epiphyses\\:\\ 0\\.008775098021356736\ \(0\)\
\-\ encapsulated\\:\\ 0\\.008775098021356736\ \(0\)\
\-\ tissue\\:\\ 0\\.008730263743330144\ \(0\)\
\-\ 1\\/4\\:\\ 0\\.008682370261101604\ \(0\)\
\-\ arranged\\:\\ 0\\.008682370261101604\ \(0\)\
\-\ abuts\\:\\ 0\\.008682370261101604\ \(0\)\
\-\ ewings\\:\\ 0\\.008682370261101604\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.008595265919411324\ \(0\)\
\-\ to\\:\\ 0\\.008590450457186505\ \(0\)\
\-\ tumor\\:\\ 0\\.008587208196598323\ \(0\)\
\-\ mottled\\:\\ 0\\.008513141761595308\ \(0\)\
\-\ angles\\:\\ 0\\.008513141761595308\ \(0\)\
\-\ an\\:\\ 0\\.008488971726183403\ \(0\)\
\-\ decreases\\:\\ 0\\.008361761710362797\ \(0\)\
\-\ dimensions\\:\\ 0\\.008361761710362797\ \(0\)\
\-\ well\\:\\ 0\\.00833224548693384\ \(0\)\
\-\ periosteum\\:\\ 0\\.008291660899774532\ \(0\)\
\-\ \\,\\:\\ 0\\.008167976114745741\ \(0\)\
\-\ width\\:\\ 0\\.008160954321892741\ \(0\)\
\-\ along\\:\\ 0\\.008115097347294587\ \(0\)\
\-\ x\\:\\ 0\\.008100765331458268\ \(0\)\
\-\ physeal\\:\\ 0\\.008099805450601369\ \(0\)\
\-\ going\\:\\ 0\\.008099805450601369\ \(0\)\
\-\ rt\\:\\ 0\\.007984801560265826\ \(0\)\
\-\ localization\\:\\ 0\\.007984801560265826\ \(0\)\
\-\ body\\:\\ 0\\.007974895726118059\ \(0\)\
\-\ lateral\\:\\ 0\\.00795977605872651\ \(0\)\
\-\ ecchymosis\\:\\ 0\\.007779196899862561\ \(0\)\
\-\ layering\\:\\ 0\\.007779196899862561\ \(0\)\
\-\ adjacent\\:\\ 0\\.007763897253259388\ \(0\)\
\-\ towards\\:\\ 0\\.007599364797917151\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.007599364797917151\ \(0\)\
\-\ be\\:\\ 0\\.007573314501976604\ \(0\)\
\-\ show\\:\\ 0\\.007537804409458696\ \(0\)\
\-\ lesion\\:\\ 0\\.007502393215519201\ \(0\)\
\-\ some\\:\\ 0\\.007456690384674595\ \(0\)\
\-\ production\\:\\ 0\\.007439557850919702\ \(0\)\
\-\ distance\\:\\ 0\\.007402236749765592\ \(0\)\
\-\ closely\\:\\ 0\\.007402236749765592\ \(0\)\
\-\ destructive\\:\\ 0\\.007365860588868623\ \(0\)\
\-\ doing\\:\\ 0\\.007295759778280358\ \(0\)\
\-\ from\\:\\ 0\\.007278366167552944\ \(0\)\
\-\ fairly\\:\\ 0\\.007196632089362325\ \(0\)\
\-\ uniform\\:\\ 0\\.007196632089362325\ \(0\)\
\-\ probable\\:\\ 0\\.007074278916459585\ \(0\)\
\-\ perfusion\\:\\ 0\\.006988900438771653\ \(0\)\
\-\ frank\\:\\ 0\\.006988900438771653\ \(0\)\
\-\ medially\\:\\ 0\\.006988900438771653\ \(0\)\
\-\ scan\\:\\ 0\\.00687434327710626\ \(0\)\
\-\ illness\\:\\ 0\\.006832004904339194\ \(0\)\
\-\ epiphysis\\:\\ 0\\.006736183963967538\ \(0\)\
\-\ blood\\:\\ 0\\.00670233066813017\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.006646355864856426\ \(0\)\
\-\ excluded\\:\\ 0\\.006646355864856426\ \(0\)\
\-\ acquired\\:\\ 0\\.0065824883898983316\ \(0\)\
\-\ across\\:\\ 0\\.006561814916547613\ \(0\)\
\-\ \\:\\:\\ 0\\.0064958322758084195\ \(0\)\
\-\ equal\\:\\ 0\\.0064248750030356525\ \(0\)\
\-\ particularly\\:\\ 0\\.0063344815757216165\ \(0\)\
\-\ leukemia\\:\\ 0\\.006299858656786184\ \(0\)\
\-\ a\\:\\ 0\\.006268100316098584\ \(0\)\
\-\ end\\:\\ 0\\.006233019553862487\ \(0\)\
\-\ metaphysis\\:\\ 0\\.00610800320761302\ \(0\)\
\-\ overall\\:\\ 0\\.00610800320761302\ \(0\)\
\-\ elevation\\:\\ 0\\.00606379105435619\ \(0\)\
\-\ \\/\\:\\ 0\\.00606379105435619\ \(0\)\
\-\ erythema\\:\\ 0\\.0060350544642604\ \(0\)\
\-\ entire\\:\\ 0\\.0060350544642604\ \(0\)\
\-\ smaller\\:\\ 0\\.005952140214805448\ \(0\)\
\-\ suspicious\\:\\ 0\\.00591241100312368\ \(0\)\
\-\ invasion\\:\\ 0\\.00591241100312368\ \(0\)\
\-\ of\\:\\ 0\\.0058586681435770045\ \(0\)\
\-\ dense\\:\\ 0\\.005799418004101967\ \(0\)\
\-\ associated\\:\\ 0\\.005794432649160063\ \(0\)\
\-\ short\\:\\ 0\\.005787394656874213\ \(0\)\
\-\ involve\\:\\ 0\\.005787394656874213\ \(0\)\
\-\ without\\:\\ 0\\.005781647029764828\ \(0\)\
\-\ phase\\:\\ 0\\.00577547108961172\ \(0\)\
\-\ scattered\\:\\ 0\\.0057172938462859485\ \(0\)\
\-\ filled\\:\\ 0\\.00570593582975274\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.00570593582975274\ \(0\)\
\-\ local\\:\\ 0\\.005639611057104518\ \(0\)\
\-\ regions\\:\\ 0\\.005618166157367915\ \(0\)\
\-\ component\\:\\ 0\\.0056075625549288025\ \(0\)\
\-\ overlying\\:\\ 0\\.0055556875482590945\ \(0\)\
\-\ segment\\:\\ 0\\.005356209897606486\ \(0\)\
\-\ do\\:\\ 0\\.005329846192623445\ \(0\)\
\-\ not\\:\\ 0\\.005322494274749722\ \(0\)\
\-\ underlying\\:\\ 0\\.005261820157282642\ \(0\)\
\-\ suggestive\\:\\ 0\\.005245305244314632\ \(0\)\
\-\ just\\:\\ 0\\.005127147057192546\ \(0\)\
\-\ mass\\:\\ 0\\.005122676754084329\ \(0\)\
\-\ around\\:\\ 0\\.005112102086118846\ \(0\)\
\-\ tissues\\:\\ 0\\.005039153342766226\ \(0\)\
\-\ appear\\:\\ 0\\.0050249977444285655\ \(0\)\
\-\ where\\:\\ 0\\.005010980251690973\ \(0\)\
\-\ tender\\:\\ 0\\.004983348984553203\ \(0\)\
\-\ moderate\\:\\ 0\\.004827869696277007\ \(0\)\
\-\ hours\\:\\ 0\\.004827869696277007\ \(0\)\
\-\ images\\:\\ 0\\.004710528425141822\ \(0\)\
\-\ effusion\\:\\ 0\\.00466547977041006\ \(0\)\
\-\ has\\:\\ 0\\.004611206811765166\ \(0\)\
\-\ which\\:\\ 0\\.0045837488139153695\ \(0\)\
\-\ ap\\:\\ 0\\.004490170933394307\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.004400784174052967\ \(0\)\
\-\ underwent\\:\\ 0\\.004212925338330775\ \(0\)\
\-\ enlarged\\:\\ 0\\.004189110733310354\ \(0\)\
\-\ this\\:\\ 0\\.004142832816009194\ \(0\)\
\-\ three\\:\\ 0\\.004138827914291538\ \(0\)\
\-\ left\\:\\ 0\\.004121143402038426\ \(0\)\
\-\ size\\:\\ 0\\.004116200964624671\ \(0\)\
\-\ palpation\\:\\ 0\\.00409761362118973\ \(0\)\
\-\ flow\\:\\ 0\\.0040575486736472936\ \(0\)\
\-\ study\\:\\ 0\\.004039700225373505\ \(0\)\
\-\ central\\:\\ 0\\.004039700225373505\ \(0\)\
\-\ bilaterally\\:\\ 0\\.00403262246914354\ \(0\)\
\-\ between\\:\\ 0\\.003891516575034833\ \(0\)\
\-\ t1\\:\\ 0\\.003891516575034833\ \(0\)\
\-\ and\\:\\ 0\\.0038795044338840188\ \(0\)\
\-\ normal\\:\\ 0\\.0038494610764341986\ \(0\)\
\-\ as\\:\\ 0\\.003714303177856689\ \(0\)\
\-\ only\\:\\ 0\\.0036916834173634132\ \(0\)\
\-\ decreased\\:\\ 0\\.003650512072880114\ \(0\)\
\-\ infection\\:\\ 0\\.003568989330564378\ \(0\)\
\-\ lymphoma\\:\\ 0\\.003508906083892939\ \(0\)\
\-\ abnormal\\:\\ 0\\.0035015693107972863\ \(0\)\
\-\ weeks\\:\\ 0\\.0034845944783062476\ \(0\)\
\-\ t2\\:\\ 0\\.0034749838631470574\ \(0\)\
\-\ edema\\:\\ 0\\.003472591220447257\ \(0\)\
\-\ 4\\:\\ 0\\.0034209366453721913\ \(0\)\
\-\ however\\:\\ 0\\.0034186322637888944\ \(0\)\
\-\ low\\:\\ 0\\.0034140345587160914\ \(0\)\
\-\ high\\:\\ 0\\.0033599799728115166\ \(0\)\
\-\ trauma\\:\\ 0\\.003357771238157944\ \(0\)\
\-\ are\\:\\ 0\\.0033473387141655223\ \(0\)\
\-\ been\\:\\ 0\\.0033402225423333205\ \(0\)\
\-\ at\\:\\ 0\\.003326905611585152\ \(0\)\
\-\ significant\\:\\ 0\\.0033015045273767575\ \(0\)\
\-\ cm\\:\\ 0\\.003293040399162336\ \(0\)\
\-\ enhancement\\:\\ 0\\.003290932135234247\ \(0\)\
\-\ therapy\\:\\ 0\\.003282529879656053\ \(0\)\
\-\ mild\\:\\ 0\\.003233122778636691\ \(0\)\
\-\ anterior\\:\\ 0\\.0031620586548315194\ \(0\)\
\-\ both\\:\\ 0\\.003135344814204197\ \(0\)\
\-\ over\\:\\ 0\\.0031259232616953486\ \(0\)\
\-\ on\\:\\ 0\\.0031202198808854657\ \(0\)\
\-\ more\\:\\ 0\\.003070655616827825\ \(0\)\
\-\ in\\:\\ 0\\.003027278952157004\ \(0\)\
\-\ into\\:\\ 0\\.0029214459309765905\ \(0\)\
\-\ noted\\:\\ 0\\.0029100879144433817\ \(0\)\
\-\ or\\:\\ 0\\.002877938933803757\ \(0\)\
\-\ posterior\\:\\ 0\\.002829940443538001\ \(0\)\
\-\ demonstrate\\:\\ 0\\.002825362272030231\ \(0\)\
\-\ mri\\:\\ 0\\.0028207986421187065\ \(0\)\
\-\ can\\:\\ 0\\.002784802230559008\ \(0\)\
\-\ lower\\:\\ 0\\.002761296076672216\ \(0\)\
\-\ it\\:\\ 0\\.0027598396329497365\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0026819270138695203\ \(0\)\
\-\ but\\:\\ 0\\.002618539225622899\ \(0\)\
\-\ multiple\\:\\ 0\\.00258592816591849\ \(0\)\
\-\ also\\:\\ 0\\.0024204304506755046\ \(0\)\
\-\ within\\:\\ 0\\.002342142828140922\ \(0\)\
\-\ that\\:\\ 0\\.0021206619663201483\ \(0\)\
\-\ for\\:\\ 0\\.0020951383581687215\ \(0\)\
\-\ \\.\\:\\ 0\\.0017341727403876056\ \(0\)\
\-\ ct\\:\\ 0\\.0017173903065977629\ \(0\)\
\-\ history\\:\\ 0\\.0016957105426825912\ \(0\)\
\-\ with\\:\\ 0\\.0015129850356451259\ \(0\)\
\-\ pain\\:\\ 0\\.001499437022314274\ \(0\)\
\-\ patient\\:\\ 0\\.0012307355329258447\ \(0\)\
\-\ \\(\\:\\ 0\\.0010378760434538226\ \(0\)\
\-\ \\)\\:\\ 0\\.001025197833496128\ \(0\)\
